Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5310-5314

  Jarrard, David F ^a,b,c,e   Kinoshita, Hidefumi ^a   Shi, Yan ^a   Sandefur, Carol ^a   Hoff, Douglas ^a   Meisner, Lorraine F ^c   Chang, Chawnshang ^c   Herman, James G ^d   Isaacs, William B ^d   Nassif, Nadine ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Environmental Toxicology Center   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ARTICLE; CANCER CELL; CPG ISLAND; EXON; GENE INDUCTION; HUMAN; HUMAN CELL; MALE; METHYLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; RECEPTOR OCCUPANCY; SEQUENCE ANALYSIS; START CODON; TRANSCRIPTION REGULATION;

CPG ISLANDS; DNA METHYLATION; HUMANS; MALE; PROMOTER REGIONS (GENETICS); PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032403081     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hobisch, A., Culig, Z., Radmayr, C., Bartsch, G., Klocker, H., and Hittmair, A. Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res., 55: 3068-3072, 1995.
2. Prins, G. S., Sklarew, R. J., and Pertschuk, L. P. Image analysis of androgen receptor immunostaining in prostate cancer accurately predicts response to hormonal therapy. J. Urol., 159: 641-649, 1998.
3. Sadi, M. V., and Barrack, E. R. Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapy. Cancer (Phila.), 71: 2574-2580, 1993.
4. Tilley, W. D., Buchanan, G., Hickey, T. E., and Bentel, J. M. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. Clin. Cancer Res., 2: 277-285, 1996.
5. Taplin, M. E., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., Keer, H. N., and Balk, S. P. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N. Engl. J. Med., 332: 1393-1398, 1995.
6. Marcelli, M., Tilley, W. D., Wilson, C. M., Griffin, J. E., Wilson, J. D., and McPhaul, M. J. Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance. Mol. Endocrinol., 4: 1105-1116, 1990.
7. Quigley, C. A., De Bellis, A., Marschke, K. B., el-Awady, M. K., Wilson, E. M., and French, F. S. Androgen receptor defects: historical, clinical, and molecular perspectives [published erratum appears in Endocr. Rev., 16: 546, 1995]. Endocr. Rev., 16: 271-321, 1995.
8. Dai, J. L., Maiorino, C. A., Gkonos, P. J., and Burnstein, K. L. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells. Steroids, 61: 531-539, 1996.
9. Lyon, M. F. The X inactivation centre and X chromosome imprinting. Eur. J. Hum. Genet., 2: 255-261, 1994.
10. Grant, M., Zuccotti, M., and Monk, M. Methylation of CpG sites of two X-linked genes coincides with X-inactivation in the female mouse embryo but not in the germ line. Nat. Genet., 2: 161-166, 1992.
11. Norris, D. P., Patel, D., Kay, G. F., Penny, G. D., Brockdorff, N., Sheardown, S. A., and Rastan, S. Evidence that random and imprinted Xist expression is controlled by preemptive methylation. Cell, 77: 41-51, 1994.
12. Allen, R. C., Zoghbi, H. Y., Moseley, A. B., Rosenblatt, H. M., and Belmont, J. W. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am. J. Hum. Genet., 51: 1229-1239, 1992.
13. Mashal, R. D., Fejzo, M. L., Friedman, A. J., Mitchner, N., Nowak, R. A., Rein, M. S., Morton, C. C., and Sklar, J. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer, 11: 1-6, 1994.
14. Green, A. J., Sepp, T., and Yates, J. R. Clonality of tuberous sclerosis harmatomas shown by non-random X-chromosome inactivation. Hum. Genet., 97: 240-243, 1996.
15. Li, E., Beard, C., and Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature (Lond.), 366: 362-365, 1993.
16. Ottaviano, Y. L., Issa, J. P., Parl, F. F., Smith, H. S., Baylin, S. B., and Davidson, N. E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res., 54: 2552-2555, 1994.
17. Lapidus, R. G., Nass, S. J., Butash, K. A., Parl, F. F., Weitzman, S. A., Graff, J. G., Herman, J. G., and Davidson, N. E. Mapping of ER gene CpG island methylation by methylation-specific polymerase chain reaction. Cancer Res., 58: 2515-2519, 1998.
18. Wolf, D. A., Herzinger, T., Hermeking, H., Blaschke, D., and Horz, W. Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. Mol. Endocrinol., 7: 924-936, 1993.
19. Tilley, W. D., Wilson, C. M., Marcelli, M., and McPhaul, M. J. Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res., 50; 5382-5386, 1990.
20. Jarrard, D. F., Bova, G. S., Ewing, C. M., Pin, S. S., Nguyen, S. H., Baylin, S. B., Cairns, P., Sidransky, D., Herman, J. G., and Isaacs, W. B. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer. Genes Chromosomes Cancer, 19: 90-96, 1997.
21. Mizokami, A., Yeh, S. Y., and Chang, C. Identification of 3′,5′-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. Mol. Endocrinol., 8: 77-88, 1994.
22. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
23. Moreno, J. G., Croce, C. M., Fischer, R., Monne, M., Vihko, P., Mulholland, S. G., and Gomella, L. G. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52: 6110-6112, 1992.
24. Seabright, M. Rapid binding technique for human chromosomes. Lancet, 11: 971-974, 1971.
25. Gardiner-Garden, M., and Frommer, M. CpG Islands in vertebrate genomes. J. Mol. Biol., 196: 261-282, 1987.
26. Tilley, W. D., Marcelli, M., and McPhaul, M. J. Expression of the human androgen receptor gene utilizes a common promoter in diverse human tissues and cell lines. J. Biol. Chem., 265: 13776-13781, 1990.
27. Brandeis, M., Frank, D., Keshet, I., Siegfried, Z., Mendelsohn, M., Nemes, A., Temper, V., Razin, A., and Cedar, H. Sp1 elements protect a CpG island from de novo methylation. Nature (Lond.), 371: 435-438, 1994.
28. Yoder, J. A., Walsh, C. P., and Bestor, T. H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet., 13: 335-340, 1997.
29. Edelstein, R. A., Carr, M. C., Caesar, R., Young, M., Atala, A., and Freeman, M. R. Detection of human androgen receptor mRNA expression abnormalities by competitive PCR. DNA Cell Biol., 13: 265-273, 1994.
30. Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., and Baylin, S. B. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res., 55: 5195-5199, 1995.
31. Ferguson, A. T., Lapidus, R. G., Baylin, S. B., and Davidson, N. E. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res., 55: 2279-2283, 1995.
32. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72: 141-196, 1998.
33. Mizokami, A., and Chang, C. Induction of translation by the 5′-untranslated region of human androgen receptor mRNA. J. Biol. Chem., 269: 25655-25659, 1994.
34. Stirzaker, C., Millar, D. S., Paul, C. L., Warnecke, P. M., Harrison, J., Vincent, P. C., Frommer, M., and Clark, S. J. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res., 57: 2229-2237, 1997.
35. Koivisto, P., Kononen, J., Palmberg, C., Tammela, T., Hyytinen, E., Isola, J., Trapman, J., Cleutjens, K., Noordzij, A., Visakorpi, T., and Kallioniemi, O. P. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res., 57: 314-319, 1997.
36. Giovannucci, E., Stampfer, M. J., Krithivas, K., Brown, M., Dahl, D., Brufsky, A., Talcott, J., Hennekens, C. H., and Kantoff, P. W. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl. Acad. Sci. USA, 94: 3320-3323, 1997.
37. Hansen, R. S., Canfield, T. K., Fjeld, A. D., and Gartler, S. M. Role of late replication timing in the silencing of X-linked genes. Hum. Mol. Genet., 5: 1345-1353, 1996.
38. Jablonka, E., Goitein, R., Sperling, K., Cedar, H., and Marcus, M. 5-aza-C-induced changes in the time of replication of the X chromosomes of Microtus agrestis are followed by non-random reversion to a late pattern of replication. Chromosoma, 95: 81-88, 1987.
39. Lengauer, C., Kinzler, K. W., and Vogelstein, B. DNA methylation and genetic instability in colorectal cancer cells [see comments], Proc. Natl. Acad. Sci. USA, 94: 2545-2550, 1997.
40. Veldscholte, J., Ris-Stalpers, C., Kuiper, G. G., Jenster, G., Berrevoets, C., Claassen, E., van Rooij, H. C., Trapman, J., Brinkmann, A. O., and Mulder, E. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun., 173: 534-540, 1990.
41. Kopp, H., and Buettner, R. Characterization of cis-regulatory elements in the human AR promoter. EMBL/Genbank, accession X78592, 1994.